Selecta Biosciences Announces Pricing of Public Offering of Common Stock

World News: . []

WATERTOWN Mass Jan 23 2019 GLOBE NEWSWIRE -- LINK  BiosciencesInc Nasdaq SELB Selecta a clinical-stage biotechnology company LINK  on unlocking the full potential of LINK  therapies based on its immune LINK  platf orm tec...

More news and information about Selecta Biosciences, Inc.

Published By:

Globe Newswire: 14:19 GMT Wednesday 23rd January 2019

Published: .

Search for other references to "selecta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us